P. Ambuhl et al., A DECREASE IN ANGIOTENSIN RECEPTOR-BINDING IN RAT-BRAIN NUCLEI BY ANTISENSE OLIGONUCLEOTIDES TO THE ANGIOTENSIN AT(1) RECEPTOR, Regulatory peptides, 59(2), 1995, pp. 171-182
Intracerebroventricular (i.c.v.) injections of antisense oligonucleoti
des against mRNA of the angiotensin type 1 (AT(1)) receptor have been
shown to reduce blood pressure in spontaneously hypertensive (SHR) rat
s and angiotensin II-induced drinking in both SHR and Sprague-Dawley (
SD) rats. The present investigation was designed to quantify the effec
t of i.c.v. injections of antisense oligonucleotides to the AT(1) rece
ptor mRNA on brain angiotensin receptors using membrane binding and au
toradiographic analysis. Control injections contained sense or scrambl
ed oligonucleotides or saline. Three daily injections of antisense oli
gonucleotides into the third ventricle of SD rats decreased the AT(1)
receptor number significantly by 25% in a hypothalamic tissue block. A
T(2) receptors were not altered. Autoradiography showed a decrease in
angiotensin receptor number in hypothalamic nuclei and in the anterove
ntral region of the third ventricle (AV3V) after antisense treatment.
AT(2) receptors were not reduced indicating the AT(1) antisense oligon
ucleotides were specific. In a second series of experiments, single in
jections of antisense oligonucleotides into the lateral ventricle of S
HR rats were tested. Antisense oligonucleotides produced a significant
decrease in receptor number in the same hypothalamic area. Sense and
scrambled oligonucleotides did not decrease the receptor numbers signi
ficantly. The decreases observed after injection of antisense oligonuc
leotides were between 15 and 30%. These changes may be sufficient to a
ccount for the physiological effects of i.c.v. injections of antisense
oligonucleotides to AT(1) receptor mRNA.